Tata India Pharma & Healthcare Fund - Direct - Growth

A Equity Scheme by Tata Asset Management Limited

3Y Returns (CAGR)
22.08%
Expense Ratio
0.79%

as of 01/05/2026

AUM
₹396.12 Cr

Qtr End: Mar 26

NAV
₹36.438

as of 03/06/2026

Historical Performance
Investment growth and SIP performance over time.
Performance Metrics
Returns, CAGR, and Volatility.
Period
Returns
CAGR
Volatility
3M4.44%18.99%15.84%
6M1.55%3.12%13.84%
1Y5.61%5.61%12.14%
3Y81.95%22.08%13.50%
5Y93.45%14.11%13.24%
Scheme Details
Launch Date
04/12/2015
Fund Age
10.5 years
Minimum Investment
₹5,000
Fund House
Tata Mutual Fund
Category
Equity Scheme
Sub-category
Sectoral/ Thematic (Equity Scheme)

Frequently Asked Questions